ROCKET ONE INC (RKTO)
NASDAQHealth CareSoftware - InfrastructureSnapshot 2026-11-05
$0.40-9.09%
Close 2026-11-05 · 1-day change
NASDAQHealth CareSoftware - InfrastructureSnapshot 2026-11-05
QuarterlyIQ Insights · RKTO
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
“This transaction is about building a larger commercial platform at the intersection of drones, public safety, artificial intelligence and defense.
Stated in a supplied disclosure. Management reported: ““This transaction is about building a larger commercial platform at the intersection of drones, public safety, artificial intelligence and defense.” “By combining Tracer’s operating capabilities with Swarm Stage AI and our broader technology portfolio, we believe Rocket One can accelerate the path from innovation to real-world deployment across autonomous, counter-UAS and mission-support applications.””
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated neutral grew net income 51% of the time over the next year (vs 41% for the rest of the cohort, n=13498).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
We develop and advance three complementary platforms: nanomagnetic AI compute, radiation-tolerant spintronic memory, and autonomous swarm defense, through exclusive licensed IP, strategic acquisition…
Stated in a supplied disclosure. Management reported: “We develop and advance three complementary platforms: nanomagnetic AI compute, radiation-tolerant spintronic memory, and autonomous swarm defense, through exclusive licensed IP, strategic acquisitions, and a capital-efficient public- company structure.” “Accepted into the AMD AI Developer Program to advance software-level architecture modeling and simulation of the nanomagnetic accelerator.”
Major General Malcolm B.
Stated in a supplied disclosure. Management reported: “Major General Malcolm B.” “: RKTO © 2026 Rocket One, Inc. 13 The Research Foundation Both spintronic platforms originate from a decade of peer-reviewed research at Virginia Commonwealth University, supported by competitive federal funding and validated through independent publication in top-tier journals.”
The Opportunity Swarm Stage AI is a swarm threat emulation and C-UAS training platform built on a commercially proven engine that has flown thousands of synchronized aircraft.
Stated in a supplied disclosure. Management reported: “The Opportunity Swarm Stage AI is a swarm threat emulation and C-UAS training platform built on a commercially proven engine that has flown thousands of synchronized aircraft.” “Rocket One press release, June 22, 2026.”
A Nasdaq-listed structure advancing through sponsored research, strategic IP acquisition, and milestone-based development.
Stated in a supplied disclosure. Management reported: “A Nasdaq-listed structure advancing through sponsored research, strategic IP acquisition, and milestone-based development.” “Pioneering spintronics inventors, a retired Major General with space and defense command experience, and a NASA astronaut and ISS Commander on the advisory board.”
Over the trailing year it converted 1.06x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
21 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Health Care names rated volatile grew net income 45% of the time over the next year (vs 45% for the rest of the cohort, n=10076).
Not investment advice. As of 2026-11-05.